Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Frontier Medicines Frontier Medicines Announces Milestone Payment in AbbVie Partnership, Following Advancement of Lead Candidates Targeting a Historically Undruggable Transcription Factor July 23, 2024 From Frontier Medicines Via GlobeNewswire Frontier Medicines Appoints Gerardo Ubaghs as Chief Financial Officer and Announces $20 Million Series C Extension June 25, 2024 From Frontier Medicines Via GlobeNewswire Frontier Medicines Presents New Data for First-In-Class Dual ON+OFF KRAS G12C Inhibitor FMC-376 at the AACR Annual Meeting April 09, 2024 From Frontier Medicines Via GlobeNewswire Frontier Medicines to Present Preclinical Data at the American Association for Cancer Research Annual Meeting 2024 March 06, 2024 From Frontier Medicines Via GlobeNewswire Frontier Medicines to Participate in Upcoming Investor Conferences February 27, 2024 From Frontier Medicines Via GlobeNewswire Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline February 22, 2024 From Frontier Medicines Via GlobeNewswire Tickers GLPG Frontier Medicines to Present at the 42nd Annual J.P. Morgan Healthcare Conference January 03, 2024 From Frontier Medicines Via GlobeNewswire Frontier Medicines Announces Appointment of Andrew Krivoshik, M.D., Ph.D., as Chief Medical Officer May 08, 2023 From Frontier Medicines Via GlobeNewswire Frontier Medicines Presents New Preclinical Data on its Development Candidate, FMC-376, a Dual KRASG12C Inhibitor, at the 2023 AACR Annual Meeting April 16, 2023 From Frontier Medicines Via GlobeNewswire Frontier Medicines to Spotlight Lead Candidate, Novel Dual KRASG12C Inhibitor FMC-376, and the Frontier™ Platform at the 2023 AACR Annual Meeting March 14, 2023 From Frontier Medicines Via GlobeNewswire Frontier Medicines Expands Leadership Team with Addition of Christo Shalish as Head of Business Development February 28, 2023 From Frontier Medicines Via GlobeNewswire Frontier Medicines Advances First Development Candidate, FMC-376, a Uniquely Differentiated Inhibitor of Both Active and Inactive KRASG12C, into IND-Enabling Studies January 05, 2023 From Frontier Medicines Via GlobeNewswire Frontier Medicines Announces Advancement of Second and Third Programs Under Global Partnership with AbbVie January 05, 2023 From Frontier Medicines Via GlobeNewswire Frontier Medicines to Present at the 41st Annual J.P. Morgan Healthcare Conference January 04, 2023 From Frontier Medicines Via GlobeNewswire Frontier Medicines Announces Appointment of Accomplished Finance and Operations Executive, Setareh “SiSi” Pouraghabagher, to Board of Directors November 08, 2022 From Frontier Medicines Via GlobeNewswire Frontier Medicines to Present at Credit Suisse 31st Annual Healthcare Conference November 01, 2022 From Frontier Medicines Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.